Wilson Sonsini Goodrich & Rosati advised Autobahn Therapeutics on the transaction.Autobahn Therapeutics, a biotechnology company, announced the closing of an oversubscribed $100 million Series C financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
